Mulakan
AbbVie, Inc.AbbVie, Inc.AbbVie, Inc.

AbbVie, Inc.

Tiada dagangan
Lihat pada Carta Super
Gambaran keseluruhan Kewangan Idea Perbincangan Teknikal Ramalan Bermusim
Bon

Bon ABBVCL

Di bawah adalah senarai bon-bon korporat AbbVie, Inc.. Pelabur selalunya memilih bon syarikat kerana kestabilan meningkat mereka semasa ketidakstabilan pasaran. Kaji harga, hasil dan statistik lain dan cari pelaburan yang boleh dipercayai.
Simbol
YTM %
Volum
Harga %
Kupon %
Tarikh Matang
Jumlah tertunggak
Nilai muka
Jumlah denominasi min
Pengeluar
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
—1.86 M82.58%4.25%2049-11-215.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030
—913 K103.38%4.88%2030-03-151 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
—26 K90.47%3.20%2029-11-2162.52 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035
—10.09 M102.98%5.20%2035-03-151 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4.40%2042-11-061.1 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
—1.33 M101.15%4.80%2027-03-152.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
—680 K91.39%4.63%2042-10-01389.22 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
—0111.17%2.95%2026-11-219.24 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
—1.36 M102.58%4.80%2029-03-152.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
—400 K90.75%4.75%2045-03-15827.09 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
—0126.76%4.75%2045-03-155 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
—57 K103.64%4.95%2031-03-152 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
—0128.71%4.85%2044-06-15100 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
—0121.31%4.25%2049-11-214.95 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
—0123.74%4.55%2035-03-151 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028
—1 M101.79%4.65%2028-03-151.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
—2.7 M98.79%2.95%2026-11-213.99 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
—680 K97.54%5.50%2064-03-151.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
—1.28 M97.26%5.40%2054-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
—9.25 M96.90%3.20%2029-11-215.44 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
—600 K98.82%5.35%2044-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055
—4.33 M100.03%5.60%2055-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
—26 K76.04%4.75%2045-03-1553.51 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
—3 K88.79%4.40%2042-11-062.6 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
—282 K92.81%4.85%2044-06-151.01 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
—817 K101.00%4.25%2028-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
—2.4 M102.53%5.05%2034-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
—16 K89.58%4.55%2035-03-15107.65 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
—9.16 M88.69%4.05%2039-11-214 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
—657 K90.74%4.88%2048-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
—12 K77.91%4.63%2042-10-0167.49 M USD1,000.00 USD2,000.00 USDActavis, Inc.
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
—16 K77.52%4.85%2044-06-1565.23 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
—4.06 M98.19%4.55%2035-03-151.68 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS212591483AbbVie Inc. 2.625% 15-NOV-2028
—0100.23%2.63%2028-11-15427.79 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
4ABBAbbVie Inc. 4.7% 14-MAY-2045
—090.19%4.70%2045-05-142.7 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS212591491AbbVie Inc. 2.125% 01-JUN-2029
—097.88%2.13%2029-06-01506.09 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
US287YAR0AbbVie Inc. 4.5% 14-MAY-2035
—097.31%4.50%2035-05-142.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029
—093.96%2.13%2029-06-0136.46 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
US287YAW9AbbVie Inc. 4.45% 14-MAY-2046
—086.65%4.45%2046-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS190919331Allergan Funding SCS 2.625% 15-NOV-2028
—090.66%2.63%2028-11-1572.11 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
4ABEAbbVie Inc. 0.75% 18-NOV-2027
—096.67%0.75%2027-11-18750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS152090781AbbVie Inc. 2.125% 17-NOV-2028
—098.71%2.13%2028-11-17750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
US287YAV1AbbVie Inc. 4.3% 14-MAY-2036
—094.93%4.30%2036-05-141 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABGAbbVie Inc. 1.25% 18-NOV-2031
—090.42%1.25%2031-11-18650 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
US287YAY5AbbVie Inc. 3.2% 14-MAY-2026
—099.32%3.20%2026-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.